©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2007; 13(31): 4264-4267
Published online Aug 21, 2007. doi: 10.3748/wjg.v13.i31.4264
Published online Aug 21, 2007. doi: 10.3748/wjg.v13.i31.4264
Table 2 Adverse events documented during treatment
| Adverse events | Group A | Group B | Group C |
| Patients (n) | 21 | 21 | 19 |
| Headache | 7 | 6 | 7 |
| Upper respiratory tract infection | 3 | 3 | 4 |
| Nasopharyngitis | 4 | 3 | 4 |
| Cough | 2 | 2 | 1 |
| Pyrexia | 3 | 3 | 4 |
| Upper abdominal pain | 2 | 2 | 1 |
| Fatigue | 5 | 6 | 5 |
| Diarrhea | 7 | 6 | 6 |
| Death | 0 | 0 | 0 |
| ALT > 2 × baseline > and 10 × ULN | 4 | 1 | 2 |
- Citation: Ren FY, Piao DM, Piao XX. A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B. World J Gastroenterol 2007; 13(31): 4264-4267
- URL: https://www.wjgnet.com/1007-9327/full/v13/i31/4264.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i31.4264